Skip to main content
Thomas Gajewski, MD, Oncology, Chicago, IL

Thomas F Gajewski MD

Oncology•Chicago, IL

Professor of Medicine, University of Chicago Medicine

Join to view full profile

  • 5841 S Maryland AveChicago, IL 60637

  • Phone+1 888-824-0200

  • Fax+1 773-702-3163

Dr. Gajewski is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Gajewski's full profileAlready have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1995 - 1997
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1991 - 1993
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1991

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1995 - 2029

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Microbiome in Cancer Immunotherapy: Diagnostic Tools and Therapeutic Strategies  
    Thomas Gajewski, MD, Science Magazine

Lectures

  • Evaluation of Imaging Techniques in Immune Checkpoint Therapy 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • UChicago Cancer Researchers Share Advances at 2026 AACR Annual Meeting
    UChicago Cancer Researchers Share Advances at 2026 AACR Annual MeetingMay 13th, 2026
  • Decades in the Making, Cancer Immunotherapy Is on the Rise
    Decades in the Making, Cancer Immunotherapy Is on the RiseAugust 4th, 2025
  • Daily Takeaways from the AACR Annual Meeting 2025: Sunday, April 27
    Daily Takeaways from the AACR Annual Meeting 2025: Sunday, April 27April 27th, 2025

Grant Support

  • Overcoming resistance to anti-PD1 immunotherapyUNIVERSITY OF CHICAGO2016–2030
  • Program 3 (Immunology And Cancer)National Cancer Institute2008–2012
  • Human Immunologic MonitoringNational Cancer Institute2008–2012
  • Innate Factors In Tumor Antigen Cross-PresentationNational Cancer Institute2008–2011
  • Countering Immune Resistance In The Melanoma Tumor MicroenvironmentNational Cancer Institute2007–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Thomas Gajewski, Dr. Thomas Gajewski, MD, Dr. T Gajewski, Dr. Thomas F Gajewski